These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of transdermal clonidine in the hypertensive patient with chronic renal failure. Lowenthal DT, Saris SD, Paran E, Cristal N. Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406 [Abstract] [Full Text] [Related]
4. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators. Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525 [Abstract] [Full Text] [Related]
10. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats. Ishii R, Tagawa T, Ishida T, Naruse T. Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146 [Abstract] [Full Text] [Related]
11. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose. Klein C, Morton N, Kelley S, Metz S. J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715 [Abstract] [Full Text] [Related]
13. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends]. Lozano A, Benavides B, Quirós P, Jiménez-Moreno J, Figueroa E, Fernández-Marchena D, García-Pérez MA, Fernández-Ruiz E. Nefrologia; 2006 Dec; 26(6):695-702. PubMed ID: 17227247 [Abstract] [Full Text] [Related]